ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

First-line medications used to treat tobacco dependence in adults

First-line medications used to treat tobacco dependence in adults
Drug OTC? (United States) Dosing Administration* Common adverse effects Advantages Disadvantages and precautions Other notes
Nicotine patch Yes

21 mg for >10 cigarettes/day

14 mg for ≤10 cigarettes/day

Apply 1 new patch daily

May start patch before quit date

Rotate application site

Tapering dose is not required

Skin irritation, insomnia, vivid dreams

Provides steady nicotine level

Easiest nicotine product to use
User cannot alter nicotine level in case of craving If removed before bedtime, takes 30 minutes to 3 hours after reapplication to reach effective levels
Nicotine gum Yes

2 mg if first cigarette ≥ 30 minutes after waking

4 mg if first cigarette <30 minutes after waking

1 piece every hour as needed

Maximum: ≤24 pieces/day

No food or drink for 30 minutes before and during use
Mouth irritation, jaw soreness, heartburn, hiccups, or nausea (gastrointestinal side effects usually due to overly vigorous chewing)

User controls nicotine dose

Oral substitute for cigarettes

Unpleasant taste

Can damage dental work

Difficult for denture wearers to use
Proper chewing technique required ("chew and park")
Nicotine lozenge Yes

2 mg if first cigarette ≥30 minutes after waking

4 mg if first cigarette <30 minutes after waking

1 piece every 1 to 2 hours as needed

Maximum:
  • 5 lozenges/6 hours
  • 20 lozenges/day

No food or drink for 30 minutes before and during use
Mouth irritation, hiccups, heartburn, or nausea

User controls nicotine dose

Oral substitute for cigarettes

Can be used by smokers with poor dentition or dentures
Unpleasant taste  
Nicotine inhaler No 10 mg per cartridge

Inhale as needed (eg, every 1 to 2 hours)

Maximum: 16 cartridges/day
Mouth and throat irritation

User controls nicotine dose

Oral substitute for cigarettes

Device visible when being used

Use caution in reactive airway disease
Frequent puffing required to obtain adequate nicotine delivery
Nicotine nasal spray No 0.5 mg per spray (10 mg/mL)

Apply 1 spray to each nostril every 1 to 2 hours as needed

Maximum:
  • 10 sprays/hour
  • 80 sprays/day
Nasal and throat irritation, rhinitis, sneezing, cough, or teary eyes

User controls nicotine dose

Most rapid delivery of nicotine among nicotine-replacement products
Local irritation to nasal mucosa is difficult for many to tolerate  
Varenicline No 0.5 mg pill to start, then titrate up to 1 mg pill

0.5 mg/day for 3 days, then 0.5 mg twice a day for 4 days, then 1 mg twice a day

Start 1 to 2 weeks before quit date

May be started up to 5 weeks prior to quit date

Abruptly quitting smoking is preferred. Gradual smoking reduction is an alternative: reduce smoking by 50% by week 4, another 50% by week 8, quit by week 12
Nausea, insomnia, abnormal (vivid, unusual, or strange) dreams, headache, skin rash (≤3%)

Dual action: relieves nicotine withdrawal and blocks reward from smoking

Oral agent (pill)

Reduced dose in severe renal insufficiency

Avoid in patients with unstable psychiatric status or history of suicidal ideation or PTSD

Monitor for neuropsychiatric symptoms
 
Bupropion sustained release No 150 mg pill

150 mg/day for 3 days, then 150 mg twice a day

Start 1 to 2 weeks before quit date

Abruptly quitting smoking is preferred. Gradual smoking reduction is an alternative: reduce smoking by 50% by week 4, another 50% by week 8, quit by week 12
Insomnia, agitation, dry mouth, headache

Blunts postcessation weight gain while being used

Oral agent (pill)

Monitor for neuropsychiatric symptoms

Contraindicated in patients with seizure disorder or predisposition
A lower dose of 150 mg/day is an option for patients who do not tolerate the full dose
OTC: over-the-counter (nonprescription) sale; PTSD: posttraumatic stress disorder; NRT: nicotine replacement therapy.
* All pharmacologic agents may be extended for an additional 12 weeks (or even longer, up to 1 year) if the patient has quit smoking but still feels at risk for relapse based upon experience with prior quit attempts. NRT may be continued indefinitely.
¶ Neuropsychiatric symptoms include: behavioral changes, hostility, agitation, depressed mood, suicidal ideation and attempts.
References:
  1. Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA 2012; 308:1573.
  2. Shahab L, Brose LS, West R. Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: Rationale, and evidence for advantages over existing systems. CNS Drugs 2013; 27:10079
Graphic 97259 Version 7.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟